The BZLF1 open reading frame of Epstein-Barr virus (EBV) encodes an important transactivator of replication. During latency, transcription of this gene is switched off. HI motifs have been shown to cause negative regulation of the promoter. Using yeast one-hybrid assays, we isolated the E boxbinding protein, E2-2, interacting with these motifs. Electrophoretic mobility shift assays demonstrated that E2-2 binds to HIa, HIb and HIc, which contain E box consensus binding sites. Deletion of the HI-associated E boxes and overexpression of E2-2 in transfection assays revealed that these elements act as repressors in lymphoid cells. In contrast, in epithelial cells they contribute to the increased responsiveness of the promoter to transactivation by the BZLF1 protein. The data presented are in accord with an alternative and exclusive binding of different cell type-and differentiation-specific factors, such as E2-2, to the HI-associated E boxes in lymphoid and epithelial cells. This implies a role in cell type-specific virus replication.
Epstein-Barr virus (EBV) establishes life-long persistence in humans. Replication of the virus depends on the type and state of differentiation of the infected cell. Whereas lymphoid cells are predominantly latently infected, differentiated epithelial cells are permissive for virus replication (Becker et al., 1991; Young et al., 1991) . It is thought that a subpopulation of resting B lymphocytes serves as a latent reservoir of EBV (Tierney et al., 1994; Miyashita et al., 1995; Decker et al., 1996; Babcock et al., 1998) . Transcription of the EBV open reading frame BZLF1, which leads to virus replication, is controlled by both down-regulation and transactivation (Flemington & Speck, 1990; Montalvo et al., 1991 Montalvo et al., , 1995 Shimizu & Takada, 1994; Walling et al., 1994; Ruf & Rawlins, 1995; Wang et al., 1997; Kraus et al., 2001) . Furthermore, a post-transcriptional mechanism interferes with processing of the primary transcript (Prang et al., 1995 (Prang et al., , 1999 , and the activity of the gene product is regulated at the post-translational level, (Daibata et al., 1992; Katz et al., 1992; Kenney et al., 1992; Sinclair et al., 1992; Gutsch et al., 1993; Zhang et al., 1994) . The objective of this work was to identify cellular proteins that interact with sequence motifs of the HI type in the promoter of BZLF1 (Schwarzmann et al., 1994) and thereby down-regulate transcriptional activity in latently infected lymphoid cells. Five copies of HI motifs are localized within 500 nucleotides upstream of the start site of transcription.
To identify HI binding factors we performed yeast one-hybrid assays (Matchmaker One Hybrid System; Clontech). As molecular baits for fishing and screening, we used the central regions of the four HI motifs HIa, HIb, HIc and HId (Schwarzmann et al., 1994) . Five copies of each individual HI sequence were fused in a head-to-tail orientation (HIa, 59-ACAGATGAACAGATG-AACAGATGAACAGATGAACAGATGA-39; HIb, 59-ACAT-ATGGACATATGGACATATGGACATATGGACATATG-39; HIc, 59-ACAGATGGACAGATGGACAGATGGACAGAT-GGACAGATGG-39; HId, 59-ACAGAGGAACAGAGGAAC-AGAGGAACAGAGGAACAGAGGA-39). These sequences were cloned in both orientations into the reporter plasmids. One of the cDNA clones, which we isolated with an HIcspecific probe, encoded the transcription factor E2-2 (Bain et al., 1993) . E2-2 belongs to the family of E box-binding proteins. Computer analysis detected putative binding sites (59-CANNTG-39) in the HI motifs HIa, HIb and HIc. No consensus sequence was found in HId. In vitro translation of the isolated E2-2 cDNA yielded a protein with the expected molecular mass (approximately 75 kDa; Fig. 1A ). However, the recombinant protein did not bind to the published consensus sequences CT1 (Pscherer et al., 1996) and mE5 (Shen & Kadesch, 1995) (data not shown). This was thought to be due to incorrect folding or missing modifications, since a monoclonal antibody specific for E2-2 (BD Pharmingen) recognized the in vitro-translated product very inefficiently (Fig. 1B, lane 4) . Therefore, further experiments were performed with E2-2-positive nuclear extracts. Native E2-2 was present in nuclear extracts of the lymphoid cell line BJAB (Fig. 1B, lane 1) (Ben Bassat et al., 1977) and in the neuroblastoma cell line NGP (Fig. 1B, lane 3) but was not detected in the teratocarcinoma cell line Tera 9117 (Fig. 1B, lane 2) .
To confirm that cellular proteins interact with the HI motifs, we performed electrophoretic mobility shift assays (EMSAs) (Fig. 2) . DNA probes with nucleotide sequences identical to those used for fishing and screening in the yeast one-hybrid assay were used. Competitor oligonucleotides were added at up to 60-fold excess. In EMSAs with BJAB extract, a number of specific protein complexes ( Fig. 2A , indicated by arrows) were formed with the four most distantly located HI sites. In lanes 2, 7, 12 and 17, the complexes are visible without competition. These HI-specific complexes were also formed in the presence of non-specific competitor oligonucleotides (Oct1: 59-TGTCGAATGCAAATCACTAGAA-39, Fig. 2A , lanes 4, 9, 14 and 19; YY1: 59-CGCTCCGCGGCCATC-TTGGCGGCTGGT-39, Fig. 2A , lanes 5, 10, 15 and 20) but disappeared when the corresponding unlabelled probes were used for competition ( Fig. 2A, lanes 3, 8, 13 and 18).
To identify those complexes containing E box-binding factors, we used the HIc sequence as a probe and challenged with the published E2-2-specific binding sites CT1 and mE5 (Fig. 2B) . It was clearly visible that both the published binding sites (Fig. 2B , lanes 4 and 5) and the unlabelled cold probe (Fig. 2B , lane 3) interfered with the formation of the slowest-migrating complex and thus demonstrated the specific binding of factors to the E boxes. In contrast, there was no competition with the mutated binding site mE5* (Fig. 2B , lane 6). The binding site for ATF (59-AGAGATTGCCTGACGTCAGAGAGCTAG-39) was also unable to compete with the E box-specific complex (Fig. 2B , lane 7). However, formation of a faster complex was significantly reduced suggesting that ATF (or a related factor) also interacted with the HI motif HIc.
To confirm that the slowest-migrating complex formed at HI-associated E boxes, the complex was challenged with binding sites HIa, HIb, HIc that had been mutated in their E boxes (HIa*: 59-CCTCCAACATGCAACTTGCCTCG-39; HIb*: 59-CTGTCCACAATACGCTGCTTCCTCC-39; HIc*: 59-CCATATGTGGACACTACGACCTGAGC-39) (Fig. 2B ).
As shown before, the CT1 site and the mE5 site abolished formation of the complex (Fig. 2B , lane 9 and 10, respectively). In contrast, the mutated HI sequences did not interfere (Fig. 2B , lanes 11-13) although they still competed with other HI-specific complexes indicated by asterisks. This demonstrated again that the E boxes localized within the HI motifs are specifically bound by proteins.
To demonstrate that the E2-2 protein interacts with the HIassociated E boxes, we performed supershift assays with an E2-2-specific monoclonal antibody. However, the antibody did not work sufficiently well in this type of assay (data not shown). In an alternative experimental approach, H1299 cells, which synthesize very low amounts of E2-2, were transiently transfected with an expression plasmid encoding E2-2 or pUC18 (as a negative control). By creating such an E2-2-positive/negative test system, we wanted to see whether we could unequivocally identify E2-2-specific complexes with HI motifs (Fig. 2C ). Using the E2-2-positive extract with the HI motifs HIa, HIb and HIc (Fig. 2C , lanes 3, 6 and 9, respectively), E2-2-specific complexes were clearly visible (indicated by arrows). These did not form or were significantly less intense with control extract of H1299 cells transfected with pUC18 (Fig. 2C , lanes 2, 5 and 8). In another shift experiment, the E2-2-specific complex, which formed with the mE5 consensus probe (Fig. 2C , lanes 12 and 23), could be competed with increasing amounts of HIa, HIb and HIc oligonucleotides (Fig. 2C, lanes 17-22) , as well as with a positive control, CT1 (Fig. 2C, lanes 15 and 16) . The EMSA with E2-2-positive/negative extracts clearly demonstrated that E2-2 does bind to the HI-associated E boxes.
Based on EMSA data, we finally performed functional transfection assays with BZLF1 promoter-derived reporter plasmids (Fig. 3) . Transfection of the Burkitt's lymphoma cell line DG75 was carried out by electroporation using double pulses: 750 V, 2350 V, 25 mF and 100 V, 2310 V, 3000 mF (Gene Pulser; Bio-Rad). The nasopharyngeal carcinoma (NPC) epithelial line CNE-L was transfected by calcium phosphate precipitation. To construct reporter plasmids, the regulatory region of BZLF1 was isolated by PCR (primers: 59-CGGCAAGGAGATCTGTTTAGTG-39 and 59-GGATCCCTAACGGTACCCCCGG-39), inserted into the reporter plasmid pGL2basic (Promega) and the E boxes were mutated by site-directed mutagenesis (QuikChange site-directed mutagenesis kit; Stratagene) using the following primers: HIa*: 59-CCTCCAACATGCAACTTGCC-TCG-39 and 59-CGAGGCAAGTTGCATGTTGGAGG-39; The HI-associated E boxes bind E2-2. The cell line H1299 was transfected with an expression plasmid for either E2-2 or pUC18. Crude nuclear extracts were prepared and used for gel retardation assays using the radiolabelled probes HIa (lanes 1-3), HIb (lanes 4-6) and HIc (lanes 7-9). Negative controls without nuclear extracts are shown in lanes 1, 4 and 7. E2-2-specific complexes that increased in intensity with extract from E2-2-transfected cells are indicated by arrows. In lanes 10-23, the E2-2-specific complexes that formed with the E2-2 consensus sequence mE5
(labelled probe) were competed with a 20-and 40-fold excess of the non-specific competitor CT2 (lanes 13 and 14), the specific competitor CT1 (lanes 15 and 16) HIb*: 59-CTGTCCACAATACGCTGCTTCCTCC-39 and 59-GGAGGAAGCAGCGTATTGTGGACAG-39; HIc*: 59-CCATATGTGGACACTACGACCTGAGC-39 and 59-GCT-CAGGTCGTAGTGTCCACATATGG-39. The reporter constructs were co-transfected with expression plasmids for BZLF1 protein (Zta) to measure the impact of E box sequences on Zta-mediated transactivation. In the lymphoid cell line (DG75), transactivation ranged from 66-to 290-fold (Fig. 3B, lanes 6-10) . Mutation of the E boxes within the HI motifs HIa and HIc increased transactivation 2?4-fold compared with the original promoter (Fig. 3B, lanes 7 and  9) . A triple mutation in the three HI motif-associated E boxes showed a cumulative effect and increased transactivation 4?4-fold compared with the original promoter (Fig. 3B , 6, 11 and 16), with mutations in the E box in HIa (lanes 2, 7, 12 and 17), with mutations in the E box in HIb (lanes 3, 8, 13 and 18), with mutations in the E box in HIc (lanes 4, 9, 14 and 19) and with mutations in all three E boxes (lanes 5, 10, 15 and 20) were co-transfected with expression plasmids for Zta/BZLF1 (lanes 6-10), E2-2 (lanes 11-15) or Zta and E2-2 (lanes 16-20). Promoter activities were calculated by measuring the concentration of the reporter protein luciferase. (C) E2-2 does not interfere with the expression of Zta from the co-transfected plasmid. DG75 cells were co-transfected with a constant amount (5 mg) of expression plasmid for Zta and increasing amounts of expression plasmids for E2-2 (0 mg, lanes 1-3; 5 mg, lanes 4-6; 10 mg, lanes 7-9 and 20 mg, lanes 10-12). Cells (2 610 5 ) from each transfection were analysed by PAGE and Western blotting with a Zta-specific polyclonal rabbit serum. In lane 13, 2 610 5 EBV-negative and Zta-negative BJAB cells were applied as a negative control. In lanes 14-18, a series of twofold dilutions of purified Zta protein were applied as a marker for quantification, starting with 5 ng protein in lane 14.
lane 10), whereas mutation of the HI motif HIb had no stimulating effect (Fig. 3B, lane 8) . In the NPC epithelial line (CNE-L) transactivation rates were quite high (up to 3000-fold) (Fig. 3A, lane 6) . The relatively strong transactivation of the original promoter in the epithelial line and the enhancement of transactivation in the lymphoid cell line after mutation of the E boxes were in accordance with the absence and presence, respectively, of E2-2 in both cell lines. (CNE-L tested negative with EMSA; data not shown.) In contrast to the lymphoid cell line, mutation of the HIassociated E boxes significantly reduced Zta-mediated transactivation in the epithelial line (Fig. 3A, lanes 7-10) . This indicated that in the latter case the E boxes were not only free of inhibitory factors but were also involved in positive regulation increasing responsiveness to Zta.
To demonstrate that E2-2 was responsible for the inhibitory effect on transactivation, both cell lines were simultaneously co-transfected with expression plasmids for E2-2 and Zta and with the reporter plasmids (Fig. 3A, B) . Both in the lymphoid and in the epithelial cell line, overexpression of E2-2 reduced transactivation. This effect was strongest in the epithelial line CNE-L with the original promoter that contained all E boxes responding to E2-2 (approx. 60 % reduction; Fig. 3A , lane 16) and decreased when the E boxes were mutated (Fig. 3A, lanes 17-20) .
In the lymphoid cell line, the E2-2 effect was less significant with the original promoter due to the high background expression of E2-2 (Fig. 3B, lane 16) . However, overexpression also significantly reduced transactivation (to 62 %) in the case of mutations in HIa (Fig. 3B , lane 17) and in HIc (Fig. 3B, lane 19) . In the case of the triple E box mutation, E2-2 reduced Zta-mediated transactivation to 43 % (Fig. 3B, lane 20) . A Western blot control of a co-transfection experiment with a Zta-specific antibody ensured that the observed transcriptional repression was not an artefact due to the inhibition of expression of Zta from the transfected vector by E2-2 (Fig. 3C ).
Since the triple mutants still responded to overexpressed E2-2, it seems likely that other E boxes outside the HI motifs confer additional repression. Indeed, three additional E boxes were localized outside the HI sequences at positions 2520 to 2515 (59-CACTTG-39), 2344 to 2339 (59-CATTTG-39) and 2208 to 2203 (59-CAACTG-39). Recently, the E box nearest to the start site of transcription was reported to be part of a silencer element (Kraus et al., 2001 ).
Thus, EMSA experiments and transfection assays have demonstrated that E box-binding proteins, in particular E2-2, interact with the core region of the HI motifs HIa, HIb and HIc in the BZLF1 promoter. Mutations of the E boxes within the HI motifs HIa and HIc released transcriptional repression in the lymphoid cell line, demonstrating their role as cell-type-specific repressors. A mutation of the E box in HIb had no influence on transactivation. In contrast to the lymphoid cells, in the epithelial cell line mutation of all three HI-associated E boxes significantly reduced Ztamediated transactivation, indicating a positive regulatory property in this type of cell.
These data suggest a model where the HI motifs HIa and HIc are bi-functional elements. Both inhibitory and stimulatory factors can bind in an exclusive manner to the same HIassociated E boxes. Inhibitory E box-binding factors such as E2-2 are expressed in a cell-type-specific manner in lymphoid cells, since mutations of HI-associated E boxes led to increased transactivation. In this context, the role of the E box in the HIb motif needs to be analysed further. In epithelial cells, such as NPC, the E boxes contribute to enhanced responsiveness to Zta-mediated transactivation by binding (epithelial) cell-type-and differentiationdependent stimulatory factors.
An alternative model is that the E boxes are situated close to positive regulatory elements with which they interfere. The inhibitory effects result from sterical hindrance or binding of histone deacetylases.
Taking into account the fact that E2-2 and other E box-binding proteins are expressed in a differentiationdependent manner in lymphoid cells Ephrussi et al., 1985; Bain et al., 1993; O'Riordan & Grosschedl, 1999) and that virus replication depends on cell differentiation, the HI motifs and the associated E boxes appear to contribute to the stabilization of latency and the control of virus replication in B lymphoid cells via binding of E box-binding proteins.
